In this episode of the EADV podcast, our host Dr Sarah Walsh meets Professor Wayne Gulliver to discuss his experience in the real world of using adalimumab in the management of hidradenitis suppurativa. They discuss practical application of scoring systems, and how early attainment of disease control might alter long-term outcomes.  

His paper, the SOLACE study, describes clinical experience in greater detail here:

https://onlinelibrary.wiley.com/doi/10.1111/jdv.17598